The PCOS Challenge Study
Part of paid clinical trials in Bethesda, Maryland.
- Sponsor
- PCOS Challenge: The National Polycystic Ovary Syndrome Association
- Study ID
- NCT05797909
- Status
- Recruiting
Conditions
- Polycystic Ovary Syndrome
Eligibility Criteria
- Sex
- FEMALE
- Age
- 12 Years - 80 Years
- Healthy Volunteers
- Accepted
Study Details
The primary purpose of The PCOS Challenge Study will be to conduct high-quality research where patients are included in the design, and answering the questions that patients identify as important to their lived experience with PCOS. In partnership with clinical investigators, patients will work on the development and management of data collection, the research agenda, and the sharing of research findings. The PCOSC Study will promote the advancement of research that provides reliable, useful, and meaningful information to patients with PCOS and their clinicians. The population for The PCOS Challenge Study will include individuals with a clinical diagnosis of PCOS, individuals self-diagnosed with PCOS, individuals with symptoms of PCOS (e.g., hirsutism, irregular menstrual cycles), and demographic-matched controls without PCOS.
Key Dates
- Start date
- Jun 22, 2022
- Status verified
- Mar 2023
- Primary completion
- Jun 30, 2042
- Completion
- Dec 31, 2042
Study Design
- Enrollment
- 15,000 participants (estimated)
Arms
- Arm: Target PopulationThe target population includes individuals diagnosed with PCOS by a healthcare provider, self-diagnosed with PCOS, or who are exhibiting PCOS Symptoms and willing to sign the consent.
- Arm: Control PopulationThe control population includes people born biologically female who have not been diagnosed with PCOS and who also do not have symptoms of PCOS.
Primary Outcome Measure
Information [ Time Frame: One Year ]
Central Contacts
- Sasha Ottey, MHA, MT (ASCP)(404) 855-7244
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| PCOS Challenge: The National Polycystic Ovary Syndrome Association | Bethesda | Maryland | 20817 |
Find similar trials in Bethesda, MD
Related Studies
- The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor AgonistsPHASE1 · Recruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health SystemRecruiting · May Health · Encino, California
- Hyperandrogenemia and Altered Day-night LH Pulse PatternsEARLY_PHASE1 · Recruiting · University of Virginia · Charlottesville, Virginia
- Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary SyndromeEARLY_PHASE1 · Recruiting · University of Virginia · Charlottesville, Virginia